This pathway has been implicated in tumor immune evasion due to the upregulation of PD-1 on tumor-infiltrating lymphocytes (TILs) and increased expression of its ligands on tumor cells, leading towards suppression of tumor-specific CD8+ T cells. Here, CD8A is linked to neoplasm.